Edge Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$98M Sell
1,615,902
-40,667
-2% -$2.47M 0.74% 43
2016
Q4
$93.1M Buy
1,656,569
+30,512
+2% +$1.79M 0.72% 43
2016
Q3
$96.8M Sell
1,626,057
-3,136
-0.2% -$183K 0.81% 37
2016
Q2
$89.6M Buy
1,629,193
+17,136
+1% +$912K 0.8% 41
2016
Q1
$81.4M Sell
1,612,057
-267,706
-14% -$13.1M 0.78% 45
2015
Q4
$94.7M Sell
1,879,763
-411,481
-18% -$20.7M 0.92% 30
2015
Q3
$108M Buy
2,291,244
+17,096
+0.8% +$908K 1.08% 23
2015
Q2
$124M Sell
2,274,148
-112
-0% -$6.28K 1.12% 17
2015
Q1
$125M Sell
2,274,260
-196,284
-8% -$11.1M 1.08% 17
2014
Q4
$134M Sell
2,470,544
-112,351
-4% -$6.26M 1.29% 12
2014
Q3
$146M Buy
2,582,895
+12,493
+0.5% +$702K 1.46% 11
2014
Q2
$142M Sell
2,570,402
-15,730
-0.6% -$858K 1.42% 12
2014
Q1
$140M Sell
2,586,132
-42,192
-2% -$2.18M 1.48% 9
2013
Q4
$126M Sell
2,628,324
-2,417,695
-48% -$111M 1.37% 14
2013
Q3
$226M Buy
5,046,019
+2,526,877
+100% +$115M 1.39% 15
2013
Q2
$112M Buy
+2,519,142
New +$113M 1.4% 13

Other funds holding MRK

Edge Asset Management's MRK Position: Q1 2017 in Review

Edge Asset Management reduced its Merck (MRK) stake by 2.5% in Q1 2017, selling an estimated $2.47M and leaving 1,615,902 shares worth $98M. The position accounts for 0.74% of the portfolio, ranked #43.

Edge Asset Management first reported a position in MRK in Q2 2013 and has held it in 16 quarters since. The position peaked at $226M in Q3 2013. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Edge Asset Management held 1,615,902 shares of Merck worth $98M as of Q1 2017.
  • Edge Asset Management sold 40,667 Merck shares in Q1 2017, an estimated $2.47M.
  • Merck made up 0.74% of Edge Asset Management's portfolio in Q1 2017, its #43 holding.
  • Edge Asset Management first reported a position in Merck in Q2 2013 and has held it in 16 quarters since.
  • Edge Asset Management's Merck position peaked at $226M in Q3 2013.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.